Search bioRxiv⌕ Search

Biology subjects

Romero, O.

Publications and source records attributed to Romero, O..

3 recordsLinked to original sources

SbmA coordinates iron homeostasis and antimicrobial susceptibility in Klebsiella pneumoniae through phosphorylation-dependent regulation

Iron is an essential nutrient that underpins fundamental biological processes, yet its bioavailability is severely restricted during infection due to oxidation and host-mediated sequestration. In Gram-negative pathogens, such as Klebsiella pneumoniae, iron limitation imposes a critical selective pressure, necessitating tightly regulated acquisition systems to support growth, virulence, and survival. While canonical pathways for iron uptake are well characterized, regulatory mechanisms coordinating these processes remain incompletely understood. Here, we applied mass spectrometry-based phosphoproteomics to identify iron-responsive regulatory events associated with bacterial iron homeostasis. This approach revealed iron-dependent phosphorylation of SbmA, a conserved inner membrane transporter previously implicated in the uptake of antimicrobial peptides and related substrates. Functional characterization demonstrated that deletion of sbmA results in reduced intracellular iron levels and altered cellular morphology, supporting a role in iron acquisition. Complementary proteome mapping of {Delta}sbmA revealed compensatory production of siderophore receptors and TonB-dependent transport systems, further implicating SbmA in maintaining iron balance. Leveraging these findings, integration with high-throughput drug screening identified a compound that exploits SbmA-mediated transport to inhibit bacterial growth, highlighting its potential as a therapeutic entry point. Collectively, this work uncovers a previously unrecognized role for SbmA in iron homeostasis and demonstrates the power of phosphoproteomics to identify condition-specific regulators of essential bacterial pathways. These findings position SbmA as a promising target for antimicrobial development in K. pneumoniae.

microbiology↗

Iron-responsive phosphorylation of TolQ modulates cell envelope integrity and antibiotic susceptibility in Klebsiella pneumoniae

Klebsiella pneumoniae is an opportunistic bacterial pathogen associated with high morbidity and mortality, exacerbated by the rapid emergence of resistance to last-resort antibiotics, such as carbapenems. Adaptation to nutrient limitation, particularly fluctuations in metal availability, is critical for bacterial survival and virulence, yet the regulatory mechanisms coordinating these responses remain incompletely understood. Protein phosphorylation represents a key post-translational modification governing bacterial physiology and offers a promising avenue for identifying novel antimicrobial targets. Here, we applied mass spectrometry-based phosphoproteomics to define nutrient-responsive signaling networks in K. pneumoniae under varying iron and zinc conditions. This analysis identified iron-dependent phosphorylation of TolQ, a conserved inner membrane component of the Tol-Pal system that maintains cell envelope integrity. Structural modeling predicted that phosphorylation modulates TolQ-TolR conformation, suggesting a mechanism by which iron availability regulates Tol-Pal function. Functional characterization demonstrated that deletion of tolQ results in reduced bacterial viability, increased susceptibility to host immune clearance, and heightened sensitivity to antibiotic treatment. To further explore the therapeutic potential of this pathway, we integrated high-throughput compound screening with computational modeling and identified small molecules that phenocopy {Delta}tolQ. Collectively, these findings reveal a previously unrecognized link between iron availability and phosphoregulation of the Tol-Pal system and establish TolQ as a critical mediator of bacterial survival. This work highlights phosphoproteomics as a powerful strategy to uncover regulatory vulnerabilities and identify targets for antimicrobial development in drug-resistant pathogens.

microbiology↗

A structure-guided pipeline yields peptide inhibitors that disarm fungal peptidase-driven virulence and resistance

Fungal infections are a major global health challenge, with current antifungal therapies limited by toxicity, cost, and resistance. For Cryptococcus neoformans, key virulence factors that initiate and sustain infection are regulated by fungal peptidases to produce a polysaccharide capsule, promote immune evasion, and support antifungal resistance. These peptidases represent promising targets for antivirulent therapeutic strategies. Here, we developed a computational pipeline to predict and design peptide- and protein-based inhibitors against cryptococcal peptidases. Specifically, we targeted three virulence-associated peptidases: Rim13 (cysteine), May1 (aspartic), and CnMpr1 (metallo). Cysteine peptidase inhibition decreased capsule/cell size ratios without impeding fungal growth and reduced fungal survival within macrophages. Similarly, aspartic peptidase inhibition enhanced fungal clearance within alveolar macrophages and disrupted biofilm formation with additive effects towards fluconazole susceptibility in resistant strains. Additionally, metallopeptidase inhibition through catalytic zinc chelation and blocked substrate binding led to enhanced enzymatic inhibition and reduced in vitro blood-brain barrier crossing. Moreover, an in vivo larval model assessing inhibitor efficacy produced additive effects with fluconazole and lacked host cell cytotoxicity and fungicidal properties, reinforcing anti-virulence mechanisms and therapeutic potential while limiting the evolution of resistance. Further, global proteome profiling of inhibitor treated cells defined a mechanism of cell wall disruption, impeding fungal virulence. Taken together, the designed peptidase inhibitors exhibited potent antifungal activity without harming mammalian cells, establishing a predictive framework for rational scaffold design of next-generation antifungals that disarm the pathogen enabling immune-mediated clearance.

microbiology↗